It has seemed odd to me that in recent months anyone that bought FITX is buying something different than someone that bought the stock 6 months prior.

Of course that is the 700/1 med. mjna allocation that us longer term holders are awaiting. I have not tried to buy more or sell FITX since last fall, but the stock apparently was being sold without the Creative Edge component. Those selling the last 2.5 months waived their claim (on those shares) to the allocation. This is IMO as the Giddy Up/Cen spin off meant different things to different people.

This should clear up as the new shares are awarded before any more buys or sells are allowed.